Outcome MeasureSafety / Adverse Events
SARA
Scale for the Assessment and Rating of Ataxia
1 Paper in Blossom
Outcome Data Across Studies
Reported results for SARA across 1 study with quantitative data.
| SD | ||||||
|---|---|---|---|---|---|---|
| Safety of ibogaine administration in detoxification of opioid dependent individuals: a descriptive open-label observational study 2021Secondary | Ibogaine single dose(experimental) | 0 | 14 | — | — | — |
| Safety of ibogaine administration in detoxification of opioid dependent individuals: a descriptive open-label observational study 2021Secondary | Ibogaine single dose(experimental) | 0.08333333333333333 | 14 | — | — | — |
| Safety of ibogaine administration in detoxification of opioid dependent individuals: a descriptive open-label observational study 2021Secondary | Ibogaine single dose(experimental) | 0.25 | 14 | — | — | — |
| Safety of ibogaine administration in detoxification of opioid dependent individuals: a descriptive open-label observational study 2021Secondary | Ibogaine single dose(experimental) | 1 | 14 | — | — | — |
Papers Using SARA
Quick Facts
- Full Name
- Scale for the Assessment and Rating of Ataxia
- Domain
- Safety / Adverse Events
- Papers Indexed
- 1
- Score Range
- 0–40
- Interpretation
- Lower = better